Valneva SE (VALN) Operating Income (2021 - 2026)

Valneva SE's (VALN) quarterly Operating Income came in at $32.5 million in Q1 2026, down 37.63% year-on-year from $52.0 million in Q1 2025, and up 113.31% quarter-over-quarter from -$243.8 million in Q4 2025.

Valneva SE (VALN) Operating Income (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Operating Income across 6 years of filings, most recently posting $32.5 million for Q1 2026.

  • Operating Income for Q1 2026 came in at $32.5 million, down 37.63% year-over-year; the trailing twelve-month figure through Mar 2026 was -$110.0 million (down 188.86% YoY), and the FY2025 annual result was -$95.5 million, down 770.59% from the prior year.
  • Operating Income came in at $32.5 million for Q1 2026 at Valneva SE, up from -$243.8 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $94.1 million in Q3 2022 to a low of -$243.8 million in Q4 2025.
  • The 5-year median for Operating Income is $32.5 million (2026), against an average of -$22.9 million.
  • Across the five-year window, Operating Income plunged 184.96% in 2023 and jumped 322.26% in 2024, its largest moves.
  • Valneva SE's Operating Income stood at -$57.5 million in 2022, then sank by 184.96% to -$163.8 million in 2023, then retreated by 13.79% to -$186.4 million in 2024, then tumbled by 30.79% to -$243.8 million in 2025, then soared by 113.31% to $32.5 million in 2026.
  • The last three Operating Income figures came in at $32.5 million (Q1 2026), -$243.8 million (Q4 2025), and $49.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -32.68 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.97 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -19.70 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -15.76 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -3.82 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.14 Bn
9 Abivax 94.26 Bn 94.26 Bn - -65.83 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 32.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.45 Mn
Dec 31, 2025 -243.81 Mn
Sep 30, 2025 49.39 Mn
Jun 30, 2025 51.91 Mn
Mar 31, 2025 52.04 Mn
Dec 31, 2024 -186.41 Mn
Sep 30, 2024 51.76 Mn
Jun 30, 2024 44.51 Mn
Mar 31, 2024 37.79 Mn
Dec 31, 2023 -163.83 Mn
Sep 30, 2023 47.79 Mn
Jun 30, 2023 -20.03 Mn
Mar 31, 2023 -17.79 Mn
Dec 31, 2022 -57.49 Mn
Sep 30, 2022 94.09 Mn
Jun 30, 2022 -140.84 Mn
Mar 31, 2022 -20.68 Mn
Dec 31, 2021 201.58 Mn
Sep 30, 2021 -178.58 Mn
Jun 30, 2021 -66.28 Mn